Weight Loss Medication
This page has been reviewed by
Dr. Nicolette Lammers.
Medication for Weight Loss
The medications listed below are part of our medical weight loss programs and are available exclusively as part of a supervised treatment. All medications require a prescription.
Your doctor will discuss suitable treatment options with you – online or via video consultation in person at:
The Body Clinic Berlin
The Body Clinic Hamburg
The Body Clinic Munich
If you qualify for treatment, your physician will provide the prescription, and—upon request—our partner pharmacy can deliver the medication directly to your home.
Saxenda
Saxenda is an injectable medication designed to help adults with obesity lose weight and maintain their weight loss. Developed by the pharmaceutical company Novo Nordisk, it is available by prescription only.
| Administration | Daily injection |
| Active ingredient | Liraglutide |
| Target group | Overweight: BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity |
| Mode of action | The medication mimics the natural GLP-1 hormone. It helps regulate appetite, enhances the feeling of fullness, and improves glucose metabolism. |
| Side effects |
The most common side effects are nausea, vomiting, diarrhea, constipation, headaches and fatigue.
Side effects Saxenda |
| Package insert |
Download the Saxenda package leaflet
Saxenda package leaflet |
| Price |
The medication is part of the holistic “Weight Loss with Injections” program. Starter month (low dosage):
|
Ozempic
Ozempic is an injectable medication used to manage type 2 diabetes. It belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. These medications work by stimulating the body’s natural GLP-1 receptors to help regulate blood glucose levels.
| Administration | Weekly injection |
| Active ingredient | Semaglutide |
| Target group | Type 2 diabetes |
| Mode of action | The medication mimics the natural GLP-1 hormone. It helps regulate appetite, enhances the feeling of fullness, and improves glucose metabolism. |
| Side effects |
The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue.
Side effects Ozempic |
| Package insert |
Download the Ozempic package leaflet
Ozempic package leaflet |
| Price | Prices for the treatment of obesity or overweight with the active ingredient semaglutide can be found below under 'Wegovy'. |
Wegovy
Wegovy contains semaglutide, an analog of the body’s natural GLP-1 hormone that regulates hunger and satiety. It can be used as an adjunct therapy for adults with obesity or overweight who have at least one obesity-related comorbidity, such as type 2 diabetes, high blood pressure, or dyslipidemia (high cholesterol).
| Administration | Weekly injection |
| Active ingredient | Semaglutide |
| Target group | Overweight: BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity |
| Mode of action | The medication mimics the natural GLP-1 hormone, helping to regulate appetite, increase feelings of fullness, and improve glucose metabolism. |
| Side effects |
The most common side effects are headaches, nausea, diarrhea, constipation, vomiting and fatigue.
Side effects Wegovy |
| Package insert |
Download the Wegovy package leaflet
Wegovy package leaflet |
| Price |
The medication is part of the holistic “Weight Loss with Injections” program. Starter month (low dosage):
|
Mounjaro
Mounjaro contains the active ingredient tirzepatide and is used to treat type 2 diabetes and support weight management. Mounjaro helps regulate feelings of hunger and fullness, lowers blood sugar levels, and enhances the body’s insulin production. It also has beneficial effects on weight loss.
| Administration | Weekly injection |
| Active ingredient | Tirzepatide |
| Target group | Type 2 diabetes & overweight: BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity |
| Mode of action | Tirzepatide activates GIP and GLP-1 receptors. This leads to increased insulin release, reduced glucagon secretion, slows gastric emptying and reduces appetite. |
| Side effects |
The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue.
Side effects Mounjaro |
| Package insert |
Download the Mounjaro package leaflet
Mounjaro package leaflet |
| Price |
The medication is part of the holistic “Weight Loss with Injections” program. Starter month (low dosage):
|
Rybelsus
Rybelsus is a drug that is used to treat type 2 diabetes. Rybelsus stimulates insulin production and reduces the amount of glucose produced by the liver. This helps to keep blood sugar levels in a healthy range and can reduce risk factors for diabetes such as heart disease, strokes and kidney damage.
| Administration | Tablet form, once daily |
| Active ingredient | Semaglutide |
| Target group | Type 2 diabetes |
| Mode of action | The medication mimics the natural GLP-1 hormone, helping to regulate appetite and enhance feelings of fullness. |
| Side effects |
The most common side effects are hypoglycemia, headache, nausea, diarrhea, constipation, vomiting and fatigue.
Side effects Rybelsus |
| Package insert |
Download the Rybelsus package leaflet.
Rybelsus package leaflet |
| Price | Rybelsus, i.e. the brand name for the oral dosage form of semaglutide, is currently not marketed in Germany. |
Mysimba
| Administration | Tablet form, 2x daily |
| Active ingredient | Naltrexone / bupropion |
| Target group | Overweight: BMI ≥30 or BMI ≥27 with at least one weight-related comorbidity |
| Mode of action | The drug acts on the body's craving system and prevents impulsive eating. |
| Side effects |
The most common side effects are dizziness, headaches, palpitations, tiredness and insomnia.
Side effects Mysimba |
| Package insert |
Download the Mysimba package leaflet.
Mysimba package leaflet |
| Price | Even if Mysimba is not on the market in Germany, it can be prescribed, imported and dispensed via individual import. Please contact us for price information. |